Home / Health / Vision Loss Risk: GLP-1 Meds Under Scrutiny
Vision Loss Risk: GLP-1 Meds Under Scrutiny
24 Feb
Summary
- GLP-1 weight loss medications may increase macular degeneration risk.
- Smoking is a major risk factor for age-related macular degeneration.
- Healthy diet, exercise, and supplements can lower AMD risk.

Recent research indicates a potential link between GLP-1 weight loss medications and an increased risk of macular degeneration. This condition, affecting millions over 50, degrades central vision and has no cure, making early detection and prevention vital.
Ophthalmologists highlight that genetics and aging are primary risk factors for age-related macular degeneration (AMD). However, crucial lifestyle changes can significantly mitigate these risks. Quitting smoking, a major contributor to oxidative stress on retinal cells, is strongly advised to delay AMD progression and treatment resistance.




